Protara Therapeutics, Inc. Class of Warrant or Right, Outstanding
Protara Therapeutics, Inc. (TARA) had Class of Warrant or Right, Outstanding of 3.40 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-11
- 2026-06-30: Class of Warrant or Right, Outstanding 3.40M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 13.15M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 13.52M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 3.40M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 13.15M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 13.52M shares 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |